Skip Nav

Clinical Guidelines Portal

Home > Guidelines > Adult and Adolescent ARV Guidelines > Appendix B: Drug Characteristics Tables
Text Size

Updated Adult and Adolescent ARV Guidelines

The Adult and Adolescent ARV Guidelines were updated on February 12, 2013. 

Please send your comments with the subject line "Comments on Adult and Adolescent ARV Guidelines" to ContactUs@aidsinfo.nih.gov by February 26, 2013.

Search Search Help

Guideline Search

Type your search term(s) in the text box. Users can only search one guideline at a time. To search for an exact phrase, use quotation marks (i.e. "what to start"). To narrow your search, add additional relevant terms. If you are not finding what you need, try searching similar terms (i.e. perinatal OR pregnancy) to broaden your search.Close

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents

Appendix B: Drug Characteristics Tables

Printer-Friendly Files

Appendix B, Table 1. Characteristics of Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

Appendix B, Table 2. Characteristics of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Appendix B, Table 3. Characteristics of Protease Inhibitors (PIs)

Appendix B, Table 4. Characteristics of Integrase Inhibitors

Appendix B, Table 5. Characteristics of Fusion Inhibitor

Appendix B, Table 6. Characteristics of CCR5 Antagonist

Appendix B, Table 7. Antiretroviral Dosing Recommendations in Patients with Renal or Hepatic Insufficiency

Appendix B, Table 8. Monthly Suggested Wholesale Price (SWP) of Antiretroviral Drugs